Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.
Prins, J B, Bleijenberg, G, Bazelmans, E et al. · Lancet (London, England) · 2001 · DOI
Quick Summary
This study tested whether cognitive behaviour therapy (CBT)—a type of talking therapy that focuses on thoughts and behaviours—helps people with ME/CFS. Researchers compared CBT with support groups and no treatment across three hospitals, following 278 patients for 14 months. CBT showed modest benefits for fatigue and daily functioning compared to the other groups, though only about one-third to one-half of patients experienced meaningful improvement.
Why It Matters
This study is one of the first rigorous multicentre trials testing whether CBT—a widely recommended treatment—actually benefits ME/CFS patients in routine clinical settings with standard-trained therapists. The finding that CBT outperformed controls provides evidence supporting its use, while the modest absolute improvement rates highlight that it is not a cure and that not all patients benefit equally.
Observed Findings
At 14 months, CBT produced significantly greater reductions in fatigue severity compared to support groups (mean difference 5.8) and natural course (5.6).
Clinically significant improvement in fatigue severity occurred in only 35% (20/58) of CBT patients.
Functional impairment improved significantly more in CBT than control conditions, with mean differences of 222–263 points on the Sickness Impact Profile.
Prognostic factors included higher sense of control predicting better outcomes, while passive activity patterns and symptom-focusing predicted poorer outcomes after CBT.
Support groups were not significantly more effective than natural course alone.
Inferred Conclusions
CBT is more effective than guided support groups or no treatment for reducing fatigue and improving function in ME/CFS, though effect sizes are moderate.
Therapist training level and implementation context affect outcome rates; outcomes were lower than in prior trials using highly skilled specialists.
Patient characteristics such as sense of control and activity coping style may predict treatment response and could guide patient selection.
Remaining Questions
Why do approximately 50–65% of CBT-treated patients fail to achieve clinically meaningful improvement, and can baseline characteristics better identify who will and will not benefit?
What This Study Does Not Prove
This study does not prove CBT cures ME/CFS or works equally well for all patients. The improvement rates (35–50%) mean that many patients saw no clinically significant change, and the study cannot explain why some patients benefit while others do not. Additionally, the study design cannot determine whether improvements were due to CBT's specific techniques or to non-specific factors like attention and hope.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
How do therapist skill level, years of experience, and specific training intensity influence CBT outcomes in ME/CFS?
What mechanisms of action drive improvement in responders, and are cognitive-behavioural techniques directly therapeutic or does benefit arise through increased physical activity and deconditioning?
Does CBT remain effective over longer follow-up periods, and what is the durability of improvements at 12 months or beyond?